Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03810872
Title An Explorative Study of Afatinib in the Treatment of Advanced Cancer Carrying an EGFR, a HER2 or a HER3 Mutation
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors AZ-VUB
Indications
Therapies
Age Groups: senior | adult
Covered Countries BEL


No variant requirements are available.